Showing results (41-50 of 69) with videos related to
Sort By:
Pageof 7
European Journal of Breast Health|October 5, 2023
Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer ChemopreventionFatma Nihan Akkoc Mustafayev, Diane D Liu, Angelica M Gutierrez, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2026
Ionizing radiation enhances prognostically significant cellular immunity programs in the brain metastasis microenvironmentKazutaka Fukumura, Peixin Jiang, Debra Nana Yeboa, et al.Journal of Cancer|August 19, 2017
Rapid Breast Cancer Disease Progression Following Cyclin Dependent Kinase 4 and 6 Inhibitor DiscontinuationSami I Bashour, Iman Doostan, Khandan Keyomarsi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2016
TBCRC-010: Phase I/II Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone MetastasisZahi Mitri, Rita Nanda, Kimberly Blackwell, et al.Clinical Breast Cancer|April 28, 2015
Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast CancerAna M Gonzalez-Angulo, Xiudong Lei, Richardo H Alvarez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2010
Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancersGiampaolo Bianchini, Yuan Qi, Ricardo H Alvarez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancerCatherine M Kelly, Marjorie C Green, Kristine Broglio, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancerSharon H Giordano, Daniel J Booser, James L Murray, et al.Nature Communications|June 28, 2017
CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancersSmruthi Vijayaraghavan, Cansu Karakas, Iman Doostan, et al.Cancer Medicine|December 19, 2019
Phase II study of Radium-223 dichloride combined with hormonal therapy for hormone receptor-positive, bone-dominant metastatic breast cancerNaoto T Ueno, Rie K Tahara, Takeo Fujii, et al.Pageof 7